2018-2023 Global Human Rabies Immunoglobulin (IM) Consumption Market Report

Publisher Name :
Date: 12-Sep-2018
No. of pages: 167

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Human Rabies Immunoglobulin (IM) market for 2018-2023.

Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.

Figure Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient's passive immunization.

In this report, we study ERIG (Equine Rabies Immunoglobulin) and HRIG (Human Rabies Immunoglobulin)

Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure. It is given after the wound is cleaned with soap and water or providone-iodine and is followed by a course of rabies vaccine.

The use of rabies immunoglobulin in the form of blood serum dates from 1891. Use become common within medicine in the 1950s. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.

The classification according to the material of Human Rabies Immunoglobulin (IM) includes ERIG, HRIG, and the proportion of HRIG in 2017is about 86.7%, and the proportion is in increasing trend from 2013 to 2017.

Over the next five years, LPI(LP Information) projects that Human Rabies Immunoglobulin (IM) will register a 7.3% CAGR in terms of revenue, reach US$ 440 million by 2023, from US$ 290 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Rabies Immunoglobulin (IM) market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

- ERIG

- HRIG

Segmentation by application:

- Category II Exposure

- Category III Exposure

This report also splits the market by region:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

- CSL Behring

- Grifols

- Sanofi

- Sichuan Yuanda Shuyang

- CNBG

- Kamada

- CBPO

- Shuanglin Bio

- Weiguang Bio

- Shanghai RAAS

- Bharat Serum

- VINS

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Human Rabies Immunoglobulin (IM) consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

- To understand the structure of Human Rabies Immunoglobulin (IM) market by identifying its various subsegments.

- Focuses on the key global Human Rabies Immunoglobulin (IM) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Human Rabies Immunoglobulin (IM) with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Human Rabies Immunoglobulin (IM) submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

2018-2023 Global Human Rabies Immunoglobulin (IM) Consumption Market Report

Table of Contents

2018-2023 Global Human Rabies Immunoglobulin (IM) Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Rabies Immunoglobulin (IM) Consumption 2013-2023
2.1.2 Human Rabies Immunoglobulin (IM) Consumption CAGR by Region
2.2 Human Rabies Immunoglobulin (IM) Segment by Type
2.2.1 ERIG
2.2.2 HRIG
2.3 Human Rabies Immunoglobulin (IM) Consumption by Type
2.3.1 Global Human Rabies Immunoglobulin (IM) Consumption Market Share by Type (2013-2018)
2.3.2 Global Human Rabies Immunoglobulin (IM) Revenue and Market Share by Type (2013-2018)
2.3.3 Global Human Rabies Immunoglobulin (IM) Sale Price by Type (2013-2018)
2.4 Human Rabies Immunoglobulin (IM) Segment by Application
2.4.1 Category II Exposure
2.4.2 Category III Exposure
2.5 Human Rabies Immunoglobulin (IM) Consumption by Application
2.5.1 Global Human Rabies Immunoglobulin (IM) Consumption Market Share by Application (2013-2018)
2.5.2 Global Human Rabies Immunoglobulin (IM) Value and Market Share by Application (2013-2018)
2.5.3 Global Human Rabies Immunoglobulin (IM) Sale Price by Application (2013-2018)

3 Global Human Rabies Immunoglobulin (IM) by Players
3.1 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Players
3.1.1 Global Human Rabies Immunoglobulin (IM) Sales by Players (2016-2018)
3.1.2 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Players (2016-2018)
3.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Players
3.2.1 Global Human Rabies Immunoglobulin (IM) Revenue by Players (2016-2018)
3.2.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Players (2016-2018)
3.3 Global Human Rabies Immunoglobulin (IM) Sale Price by Players
3.4 Global Human Rabies Immunoglobulin (IM) Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Human Rabies Immunoglobulin (IM) Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Human Rabies Immunoglobulin (IM) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Human Rabies Immunoglobulin (IM) by Regions
4.1 Human Rabies Immunoglobulin (IM) by Regions
4.1.1 Global Human Rabies Immunoglobulin (IM) Consumption by Regions
4.1.2 Global Human Rabies Immunoglobulin (IM) Value by Regions
4.2 Americas Human Rabies Immunoglobulin (IM) Consumption Growth
4.3 APAC Human Rabies Immunoglobulin (IM) Consumption Growth
4.4 Europe Human Rabies Immunoglobulin (IM) Consumption Growth
4.5 Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption Growth

5 Americas
5.1 Americas Human Rabies Immunoglobulin (IM) Consumption by Countries
5.1.1 Americas Human Rabies Immunoglobulin (IM) Consumption by Countries (2013-2018)
5.1.2 Americas Human Rabies Immunoglobulin (IM) Value by Countries (2013-2018)
5.2 Americas Human Rabies Immunoglobulin (IM) Consumption by Type
5.3 Americas Human Rabies Immunoglobulin (IM) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Human Rabies Immunoglobulin (IM) Consumption by Countries
6.1.1 APAC Human Rabies Immunoglobulin (IM) Consumption by Countries (2013-2018)
6.1.2 APAC Human Rabies Immunoglobulin (IM) Value by Countries (2013-2018)
6.2 APAC Human Rabies Immunoglobulin (IM) Consumption by Type
6.3 APAC Human Rabies Immunoglobulin (IM) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Human Rabies Immunoglobulin (IM) by Countries
7.1.1 Europe Human Rabies Immunoglobulin (IM) Consumption by Countries (2013-2018)
7.1.2 Europe Human Rabies Immunoglobulin (IM) Value by Countries (2013-2018)
7.2 Europe Human Rabies Immunoglobulin (IM) Consumption by Type
7.3 Europe Human Rabies Immunoglobulin (IM) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Human Rabies Immunoglobulin (IM) by Countries
8.1.1 Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Human Rabies Immunoglobulin (IM) Value by Countries (2013-2018)
8.2 Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption by Type
8.3 Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Human Rabies Immunoglobulin (IM) Distributors
10.3 Human Rabies Immunoglobulin (IM) Customer

11 Global Human Rabies Immunoglobulin (IM) Market Forecast
11.1 Global Human Rabies Immunoglobulin (IM) Consumption Forecast (2018-2023)
11.2 Global Human Rabies Immunoglobulin (IM) Forecast by Regions
11.2.1 Global Human Rabies Immunoglobulin (IM) Forecast by Regions (2018-2023)
11.2.2 Global Human Rabies Immunoglobulin (IM) Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Human Rabies Immunoglobulin (IM) Forecast by Type
11.8 Global Human Rabies Immunoglobulin (IM) Forecast by Application

12 Key Players Analysis
12.1 CSL Behring
12.1.1 Company Details
12.1.2 Human Rabies Immunoglobulin (IM) Product Offered
12.1.3 CSL Behring Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 CSL Behring News
12.2 Grifols
12.2.1 Company Details
12.2.2 Human Rabies Immunoglobulin (IM) Product Offered
12.2.3 Grifols Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Grifols News
12.3 Sanofi
12.3.1 Company Details
12.3.2 Human Rabies Immunoglobulin (IM) Product Offered
12.3.3 Sanofi Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Sanofi News
12.4 Sichuan Yuanda Shuyang
12.4.1 Company Details
12.4.2 Human Rabies Immunoglobulin (IM) Product Offered
12.4.3 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Sichuan Yuanda Shuyang News
12.5 CNBG
12.5.1 Company Details
12.5.2 Human Rabies Immunoglobulin (IM) Product Offered
12.5.3 CNBG Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 CNBG News
12.6 Kamada
12.6.1 Company Details
12.6.2 Human Rabies Immunoglobulin (IM) Product Offered
12.6.3 Kamada Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Kamada News
12.7 CBPO
12.7.1 Company Details
12.7.2 Human Rabies Immunoglobulin (IM) Product Offered
12.7.3 CBPO Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 CBPO News
12.8 Shuanglin Bio
12.8.1 Company Details
12.8.2 Human Rabies Immunoglobulin (IM) Product Offered
12.8.3 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Shuanglin Bio News
12.9 Weiguang Bio
12.9.1 Company Details
12.9.2 Human Rabies Immunoglobulin (IM) Product Offered
12.9.3 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Weiguang Bio News
12.10 Shanghai RAAS
12.10.1 Company Details
12.10.2 Human Rabies Immunoglobulin (IM) Product Offered
12.10.3 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Shanghai RAAS News
12.11 Bharat Serum
12.12 VINS

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Human Rabies Immunoglobulin (IM)
Table Product Specifications of Human Rabies Immunoglobulin (IM)
Figure Human Rabies Immunoglobulin (IM) Report Years Considered
Figure Market Research Methodology
Figure Global Human Rabies Immunoglobulin (IM) Consumption Growth Rate 2013-2023 (K Units)
Figure Global Human Rabies Immunoglobulin (IM) Value Growth Rate 2013-2023 ($ Millions)
Table Human Rabies Immunoglobulin (IM) Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of ERIG
Table Major Players of ERIG
Figure Product Picture of HRIG
Table Major Players of HRIG
Table Global Consumption Sales by Type (2013-2018)
Table Global Human Rabies Immunoglobulin (IM) Consumption Market Share by Type (2013-2018)
Figure Global Human Rabies Immunoglobulin (IM) Consumption Market Share by Type (2013-2018)
Table Global Human Rabies Immunoglobulin (IM) Revenue by Type (2013-2018) ($ million)
Table Global Human Rabies Immunoglobulin (IM) Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Human Rabies Immunoglobulin (IM) Value Market Share by Type (2013-2018)
Table Global Human Rabies Immunoglobulin (IM) Sale Price by Type (2013-2018)
Figure Human Rabies Immunoglobulin (IM) Consumed in Category II Exposure
Figure Global Human Rabies Immunoglobulin (IM) Market: Category II Exposure (2013-2018) (K Units)
Figure Global Human Rabies Immunoglobulin (IM) Market: Category II Exposure (2013-2018) ($ Millions)
Figure Global Category II Exposure YoY Growth ($ Millions)
Figure Human Rabies Immunoglobulin (IM) Consumed in Category III Exposure
Figure Global Human Rabies Immunoglobulin (IM) Market: Category III Exposure (2013-2018) (K Units)
Figure Global Human Rabies Immunoglobulin (IM) Market: Category III Exposure (2013-2018) ($ Millions)
Figure Global Category III Exposure YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Human Rabies Immunoglobulin (IM) Consumption Market Share by Application (2013-2018)
Figure Global Human Rabies Immunoglobulin (IM) Consumption Market Share by Application (2013-2018)
Table Global Human Rabies Immunoglobulin (IM) Value by Application (2013-2018)
Table Global Human Rabies Immunoglobulin (IM) Value Market Share by Application (2013-2018)
Figure Global Human Rabies Immunoglobulin (IM) Value Market Share by Application (2013-2018)
Table Global Human Rabies Immunoglobulin (IM) Sale Price by Application (2013-2018)
Table Global Human Rabies Immunoglobulin (IM) Sales by Players (2016-2018) (K Units)
Table Global Human Rabies Immunoglobulin (IM) Sales Market Share by Players (2016-2018)
Figure Global Human Rabies Immunoglobulin (IM) Sales Market Share by Players in 2016
Figure Global Human Rabies Immunoglobulin (IM) Sales Market Share by Players in 2017
Table Global Human Rabies Immunoglobulin (IM) Revenue by Players (2016-2018) ($ Millions)
Table Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Players (2016-2018)
Figure Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Players in 2016
Figure Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Players in 2017
Table Global Human Rabies Immunoglobulin (IM) Sale Price by Players (2016-2018)
Figure Global Human Rabies Immunoglobulin (IM) Sale Price by Players in 2017
Table Global Human Rabies Immunoglobulin (IM) Manufacturing Base Distribution and Sales Area by Players
Table Players Human Rabies Immunoglobulin (IM) Products Offered
Table Human Rabies Immunoglobulin (IM) Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Human Rabies Immunoglobulin (IM) Consumption by Regions 2013-2018 (K Units)
Table Global Human Rabies Immunoglobulin (IM) Consumption Market Share by Regions 2013-2018
Figure Global Human Rabies Immunoglobulin (IM) Consumption Market Share by Regions 2013-2018
Table Global Human Rabies Immunoglobulin (IM) Value by Regions 2013-2018 ($ Millions)
Table Global Human Rabies Immunoglobulin (IM) Value Market Share by Regions 2013-2018
Figure Global Human Rabies Immunoglobulin (IM) Value Market Share by Regions 2013-2018
Figure Americas Human Rabies Immunoglobulin (IM) Consumption 2013-2018 (K Units)
Figure Americas Human Rabies Immunoglobulin (IM) Value 2013-2018 ($ Millions)
Figure APAC Human Rabies Immunoglobulin (IM) Consumption 2013-2018 (K Units)
Figure APAC Human Rabies Immunoglobulin (IM) Value 2013-2018 ($ Millions)
Figure Europe Human Rabies Immunoglobulin (IM) Consumption 2013-2018 (K Units)
Figure Europe Human Rabies Immunoglobulin (IM) Value 2013-2018 ($ Millions)
Figure Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption 2013-2018 (K Units)
Figure Middle East & Africa Human Rabies Immunoglobulin (IM) Value 2013-2018 ($ Millions)
Table Americas Human Rabies Immunoglobulin (IM) Consumption by Countries (2013-2018) (K Units)
Table Americas Human Rabies Immunoglobulin (IM) Consumption Market Share by Countries (2013-2018)
Figure Americas Human Rabies Immunoglobulin (IM) Consumption Market Share by Countries in 2017
Table Americas Human Rabies Immunoglobulin (IM) Value by Countries (2013-2018) ($ Millions)
Table Americas Human Rabies Immunoglobulin (IM) Value Market Share by Countries (2013-2018)
Figure Americas Human Rabies Immunoglobulin (IM) Value Market Share by Countries in 2017
Table Americas Human Rabies Immunoglobulin (IM) Consumption by Type (2013-2018) (K Units)
Table Americas Human Rabies Immunoglobulin (IM) Consumption Market Share by Type (2013-2018)
Figure Americas Human Rabies Immunoglobulin (IM) Consumption Market Share by Type in 2017
Table Americas Human Rabies Immunoglobulin (IM) Consumption by Application (2013-2018) (K Units)
Table Americas Human Rabies Immunoglobulin (IM) Consumption Market Share by Application (2013-2018)
Figure Americas Human Rabies Immunoglobulin (IM) Consumption Market Share by Application in 2017
Figure United States Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure United States Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure Canada Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure Canada Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure Mexico Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure Mexico Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Table APAC Human Rabies Immunoglobulin (IM) Consumption by Countries (2013-2018) (K Units)
Table APAC Human Rabies Immunoglobulin (IM) Consumption Market Share by Countries (2013-2018)
Figure APAC Human Rabies Immunoglobulin (IM) Consumption Market Share by Countries in 2017
Table APAC Human Rabies Immunoglobulin (IM) Value by Countries (2013-2018) ($ Millions)
Table APAC Human Rabies Immunoglobulin (IM) Value Market Share by Countries (2013-2018)
Figure APAC Human Rabies Immunoglobulin (IM) Value Market Share by Countries in 2017
Table APAC Human Rabies Immunoglobulin (IM) Consumption by Type (2013-2018) (K Units)
Table APAC Human Rabies Immunoglobulin (IM) Consumption Market Share by Type (2013-2018)
Figure APAC Human Rabies Immunoglobulin (IM) Consumption Market Share by Type in 2017
Table APAC Human Rabies Immunoglobulin (IM) Consumption by Application (2013-2018) (K Units)
Table APAC Human Rabies Immunoglobulin (IM) Consumption Market Share by Application (2013-2018)
Figure APAC Human Rabies Immunoglobulin (IM) Consumption Market Share by Application in 2017
Figure China Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure China Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure Japan Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure Japan Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure Korea Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure Korea Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure India Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure India Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure Australia Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure Australia Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Table Europe Human Rabies Immunoglobulin (IM) Consumption by Countries (2013-2018) (K Units)
Table Europe Human Rabies Immunoglobulin (IM) Consumption Market Share by Countries (2013-2018)
Figure Europe Human Rabies Immunoglobulin (IM) Consumption Market Share by Countries in 2017
Table Europe Human Rabies Immunoglobulin (IM) Value by Countries (2013-2018) ($ Millions)
Table Europe Human Rabies Immunoglobulin (IM) Value Market Share by Countries (2013-2018)
Figure Europe Human Rabies Immunoglobulin (IM) Value Market Share by Countries in 2017
Table Europe Human Rabies Immunoglobulin (IM) Consumption by Type (2013-2018) (K Units)
Table Europe Human Rabies Immunoglobulin (IM) Consumption Market Share by Type (2013-2018)
Figure Europe Human Rabies Immunoglobulin (IM) Consumption Market Share by Type in 2017
Table Europe Human Rabies Immunoglobulin (IM) Consumption by Application (2013-2018) (K Units)
Table Europe Human Rabies Immunoglobulin (IM) Consumption Market Share by Application (2013-2018)
Figure Europe Human Rabies Immunoglobulin (IM) Consumption Market Share by Application in 2017
Figure Germany Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure Germany Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure France Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure France Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure UK Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure UK Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure Italy Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure Italy Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure Russia Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure Russia Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure Spain Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure Spain Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption Market Share by Countries in 2017
Table Middle East & Africa Human Rabies Immunoglobulin (IM) Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Human Rabies Immunoglobulin (IM) Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Human Rabies Immunoglobulin (IM) Value Market Share by Countries in 2017
Table Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption Market Share by Type in 2017
Table Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption Market Share by Application in 2017
Figure Egypt Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure Egypt Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure South Africa Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure South Africa Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure Israel Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure Israel Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure Turkey Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure Turkey Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Table Human Rabies Immunoglobulin (IM) Distributors List
Table Human Rabies Immunoglobulin (IM) Customer List
Figure Global Human Rabies Immunoglobulin (IM) Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Human Rabies Immunoglobulin (IM) Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Human Rabies Immunoglobulin (IM) Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Human Rabies Immunoglobulin (IM) Consumption Market Forecast by Regions
Table Global Human Rabies Immunoglobulin (IM) Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Human Rabies Immunoglobulin (IM) Value Market Share Forecast by Regions
Figure Americas Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Americas Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure APAC Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure APAC Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Europe Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Europe Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Middle East & Africa Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure United States Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure United States Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Canada Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Canada Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Mexico Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Mexico Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Brazil Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Brazil Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure China Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure China Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Japan Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Japan Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Korea Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Korea Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Southeast Asia Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Southeast Asia Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure India Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure India Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Australia Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Australia Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Germany Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Germany Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure France Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure France Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure UK Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure UK Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Italy Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Italy Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Russia Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Russia Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Spain Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Spain Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Egypt Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Egypt Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure South Africa Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure South Africa Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Israel Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Israel Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Turkey Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Turkey Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure GCC Countries Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure GCC Countries Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Table Global Human Rabies Immunoglobulin (IM) Consumption Forecast by Type (2018-2023) (K Units)
Table Global Human Rabies Immunoglobulin (IM) Consumption Market Share Forecast by Type (2018-2023)
Table Global Human Rabies Immunoglobulin (IM) Value Forecast by Type (2018-2023) ($ Millions)
Table Global Human Rabies Immunoglobulin (IM) Value Market Share Forecast by Type (2018-2023)
Table Global Human Rabies Immunoglobulin (IM) Consumption Forecast by Application (2018-2023) (K Units)
Table Global Human Rabies Immunoglobulin (IM) Consumption Market Share Forecast by Application (2018-2023)
Table Global Human Rabies Immunoglobulin (IM) Value Forecast by Application (2018-2023) ($ Millions)
Table Global Human Rabies Immunoglobulin (IM) Value Market Share Forecast by Application (2018-2023)
Table CSL Behring Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Behring Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure CSL Behring Human Rabies Immunoglobulin (IM) Market Share (2016-2018)
Table Grifols Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Grifols Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Grifols Human Rabies Immunoglobulin (IM) Market Share (2016-2018)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi Human Rabies Immunoglobulin (IM) Market Share (2016-2018)
Table Sichuan Yuanda Shuyang Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Market Share (2016-2018)
Table CNBG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CNBG Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure CNBG Human Rabies Immunoglobulin (IM) Market Share (2016-2018)
Table Kamada Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kamada Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Kamada Human Rabies Immunoglobulin (IM) Market Share (2016-2018)
Table CBPO Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CBPO Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure CBPO Human Rabies Immunoglobulin (IM) Market Share (2016-2018)
Table Shuanglin Bio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Shuanglin Bio Human Rabies Immunoglobulin (IM) Market Share (2016-2018)
Table Weiguang Bio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Weiguang Bio Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Weiguang Bio Human Rabies Immunoglobulin (IM) Market Share (2016-2018)
Table Shanghai RAAS Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Shangh
  • Global Sexual Dysfunction Drugs Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 24-Sep-2018        Price: US 3480 Onwards        Pages: 136
    Sexual dysfunctions include sexual disorders of men and women that can interfere with their sexual performance, leading to unsatisfied sexual intercourse. The major drugs used in this market are PDE5 inhibitors, whereas other drugs such as hormone-related and transurethral also have a presence in the market. Scope of the Report: This report studies the Sexual Dysfunction Drugs market status and outlook of Global and major regions, from angles of players, countries, product ......
  • Global Organ Transplant Immunosuppressant Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 24-Sep-2018        Price: US 3480 Onwards        Pages: 116
    Solid organ transplantation has been rapidly developed as a therapeutic intervention that is life-saving and greatly contributes to a better quality of life in organ recipients. Organ transplant immunosuppressant drugs can prevent organ rejection post transplantation. Scope of the Report: This report focuses on the Organ Transplant Immunosuppressant Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This repo......
  • Global Lifestyle Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 24-Sep-2018        Price: US 3480 Onwards        Pages: 136
    Lifestyle drug is an term commonly applied to medications which treat non-life-threatening and non-painful conditions such as baldness, wrinkles, erectile dysfunction, or acne, which the speaker perceives as either not medical problems at all or as minor medical conditions relative to others. Proponents point out that improving the patient's subjective quality of life has always been a primary concern of medicine. Scope of the Report: This report focuses on the Lifestyle Dr......
  • 2018-2023 Global Injectable Drugs Consumption Market Report
    Published: 23-Sep-2018        Price: US 4660 Onwards        Pages: 137
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Injectable Drugs market for 2018-2023. Drug injection is a method of introducing a drug into the bloodstream via a hollow hypodermic needle and a syringe, which is pierced through the skin into the body. Injectable drugs bypasses first-pass metabolism in the liver, resulting in higher bioavailability and efficiency for many drugs (such as morphine or......
  • 2018-2023 Global Tetanus Vaccine Consumption Market Report
    Published: 23-Sep-2018        Price: US 4660 Onwards        Pages: 131
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Tetanus Vaccine market for 2018-2023. Tetanus vaccine, also known as tetanus toxoid (TT), is an inactive vaccine used to prevent tetanus. During childhood five doses are recommended, with a sixth given during adolescence. Additional doses every 10 years are recommended. After three doses almost everyone is initially immune. In those who are not up to date o......
  • Global Pediatric Medicines Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Sep-2018        Price: US 3480 Onwards        Pages: 115
    The pediatric drug market plays a pivotal role in the pharmaceutical industry. Scope of the Report: This report focuses on the Pediatric Medicines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The pediatric medicines market identifies the formulatory advancement as one of the primary factors for thi......
  • Global Photomedicine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Sep-2018        Price: US 3480 Onwards        Pages: 138
    Photomedicine is the study and treatment of diseases through exposure to light. Scope of the Report: This report focuses on the Photomedicine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The increase in SAD cases as one of the primary factors for the growth of the photomedicine market. ......
  • Global Opioid-Induced Constipation Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Sep-2018        Price: US 3480 Onwards        Pages: 137
    Opioids are administered to the patients with acute and non-cancer chronic pain. They have several adverse gastrointestinal effects, one of which is opioid-induced constipation. Opioids are administered to the patients with acute and non-cancer chronic pain. They have several adverse gastrointestinal effects, one of which is opioid-induced constipation. Scope of the Report: This report focuses on the Opioid-Induced Constipation in global market, especially in North ......
  • Global Orphan Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Sep-2018        Price: US 3480 Onwards        Pages: 136
    An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease. Scope of the Report: This report focuses on the Orphan Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. High unmet needs ar......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs